Gingival status of Brazilian renal transplant recipients under sirolimus-based regimens

Journal of Periodontology

Volumn 79, Issue 11, 2008, Pages 2060-2068

  Cota, Luís Otávio Miranda ^a   Oliveira, Ana Paula Lima ^a   Costa, José Eustáquio ^a   Cortelli, Sheila Cavalca ^b   Costa, Fernando Oliveira ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF TAUBATÉ   (Brazil)

Author keywords

Gingival overgrowth; Renal transplantation; Risk; Sirolimus

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DENTAL CARE; FEMALE; GINGIVA OVERGROWTH; HOSPITALIZATION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIODONTICS;

ADOLESCENT; ADULT; AGED; BRAZIL; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENTAL CARE FOR CHRONICALLY ILL; FEMALE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIODONTAL INDEX; SEVERITY OF ILLNESS INDEX; SIROLIMUS; YOUNG ADULT;

EID: 55749095043     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.080194     Document Type: Article

References (43)

1. Magoha GA, Ngumi ZW. Renal transplantation during the twentieth century: A review. East Afr Med J 2001;78:317-321.
2. Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004;164:1373-1388.
3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long term outcomes after renal transplantation. N Engl J Med 2002;346:580-590.
4. Rajab A, Pelletier RP, Henry ML, et al. Evolution of immunosuppression in kidney transplantation: The Ohio State University experience. Clin Transpl 2005;111-117.
5. Callaghan CJ, Bradley JA. Current status of renal transplantation. Methods Mol Biol 2006;333:1-28.
6. Dannovitch MD. Immunosuppressant-induced metabolic toxicities. Transplant Rev 2000;14:65-81.
7. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002;2:807-808.
8. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326-2333.
9. Dahm F, Weber M. Kidney transplantation: New developments. Swiss Surg 2003;9:205-212.
10. Flechner SM. Minimizing calcineurin inhibitor drugs in renal transplantation. Transplant Proc 2003;35:118S-121S.
11. Bestard O, Cruzado JM, Grinyó JM. Calcineurin-inhibitor-sparing immunosuppressive protocols. Transplant Proc 2005;37:3729-3732.
12. Barbari AG, Stephan AG, Masri MA. Calcineurim inhibitor-free protocols: Risks and benefits. Saudi J Kidney Dis Transpl 2007;18:1-23.
13. Watson CJE. Sirolimus (Rapamycin) in clinical transplantation. Transplant Rev 2001;15:165-177.
14. Flechner SM, Goldfarb D, Solez K, et al. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation 2007;83:883-892.
15. Krüger B, Fischereder M, Jauch KW, et al. Five-year follow-up after latter conversion from calcineurim inhibitors to sirolimus in patients with chronic renal allograft dysfunction. Transplant Proc 2007;39:518-521.
16. Srinivas TR, Schold JD, Guerra G, Eagan A, Bucci CM, Meier-Kriesche HU. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant 2007;7:586-594.
17. Merkel S, Mogilevskaja N, Mengel M, Haller H, Schwarz A. Side effects of sirolimus. Transplant Proc 2006;38:714-715.
18. Webster AC, Lee VW, Chapman JR, Craig JC. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials. Transplantation 2006;81:1234-1248.
19. van Gelder T. The ups and downs of sirolimus in kidney transplantation, and the importance of reporting negative findings. Neth J Med 2007;65:3-4.
20. Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004;15:165-175.
21. Kataoka M, Kido J, Shinohara Y, Nagata T. Drug-induced gingival overgrowth - A review. Biol Pharm Bull 2005;28:1817-1821.
22. Vescovi P, Meleti M, Manfredi M, Merigo E, Pedrazzi G. Cyclosporin-induced gingival overgrowth: A clinical-epidemiological evaluation of 121 Italian renal transplant recipients. J Periodontol 2005;76:1259-1264.
23. Costa FO, Ferreira SD, Cota LOM, Costa JE, Aguiar MA. Prevalence, severity, and risk variables associated with gingival overgrowth in renal transplant subjects treated under tacrolimus or cyclosporin regimens. J Periodontol 2006;77:969-975.
24. Costa FO, Ferreira SD, Lages EJP, Costa JE, Oliveira AMSD, Cota LOM. Demographic, pharmacologic, and periodontal variables for gingival overgrowth in subjects medicated with cyclosporin in the absence of calcium channel blockers. J Periodontol 2007;78:254-261.
25. Afonso M, Bello VO, Shibli JA, Sposto MR. Cyclosporin A-induced gingival overgrowth in renal transplant patients. J Periodontol 2003;74:51-56.
26. Ellis JS, Seymour RA, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol 2004;31:126-131.
27. Cezário ES, Cota LO, Ferreira SD, et al. Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers. Transplantation 2008;85:232-236.
28. Hernandéz G, Arribal L, Frias MC, et al. Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: A preliminary case series. J Periodontol 2003;74:1816-1823.
29. James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000;27:144-148.
30. James JA, Jamal S, Hull PA, et al. Tacrolimus is not associated with gingival overgrowth in renal transplant patients. J Clin Periodontol 2001;28:848-852.
31. McKaig SJ, Kelly D, Shaw L. Investigation of the effect of FK506 (tacrolimus) and cyclosporin on gingival overgrowth following paediatric liver transplantation. Int J Paediatr Dent 2002;12:398-403.
32. Silness J, Lóe H. Periodontal disease in pregnancy: II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
33. Saxer UP, Mühlemann HR. Motivation and education (in German). SSO Schweiz Monatsschr Zahnheilkd 1975;85:905-919.
34. Thomason JM, Kelly PJ, Seymour RA. The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 1996;23:367-371.
35. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
36. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007;357:2562-2575.
37. Saber LT, Ikeda MY, Almeida JM. Posttransplantation conversion to sirolimus-based immunosuppression: A single center experience. Transplant Proc 2007;39:3098-3100.
38. Ellis JS, Seymour RA, Robertson P, Butler TJ, Thomason JM. Photographic scoring of gingival overgrowth. J Clin Periodontol 2001;28:81-85.
39. Greenberg KV, Armitage GC, Shiboski CH. Gingival enlargement among renal transplant recipients in the era of new-generation immunosuppressants. J Periodontol 2008;79:453-460.
40. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27:217-223.
41. Thomason JM, Seymour RA, Ellis JS. Risk factors for gingival overgrowth in patients medicated with cyclosporin in the absence of calcium channel blockers. J Clin Periodontol 2005;32:273-279.
42. James JA, Marley JJ, Jamal S, et al. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol 2000;27:109-115.
43. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol 1999;70:63-67.